Literature DB >> 19295189

Treatment of mediastinal fibrosis with mycophenolate mofetil.

Michael Witschi1, Mathias Gugger, Laurent P Nicod.   

Abstract

We present the case of a 67-year-old male patient with mediastinal and retroperitoneal fibrosis. In Europe, this is a rare disease. Treatment was established to prevent complications due to strictures or compressions. Because of his diabetes, a therapy of low-dose prednisone combined with mycophenolate mofetil, known as steroid sparing agent, was applied. As a result, the radiological follow-up showed a marked decrease in the mediastinal and retroperitoneal masses. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295189     DOI: 10.1159/000209508

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

Review 1.  Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.

Authors:  Giovanni M Rossi; Giacomo Emmi; Domenico Corradi; Maria L Urban; Federica Maritati; Federica Landini; Paola Galli; Alessandra Palmisano; Augusto Vaglio
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

2.  Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia.

Authors:  Junjing Su; Ulf Simonsen; Jørn Carlsen; Soren Mellemkjaer
Journal:  Front Pharmacol       Date:  2017-07-20       Impact factor: 5.810

3.  Ptosis and Miosis Associated with Fibrosing Mediastinitis.

Authors:  Shakeel Ahmed; Mansoor Hameed; Merlin M Thomas; Khezar S Syed; Irfan U Haq; Abbas AlAbbas
Journal:  Am J Case Rep       Date:  2021-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.